<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Tykalova T</submitter><funding>Ministerstvo Zdravotnictví Ceské Republiky</funding><funding>Ministerstvo Zdravotnictví Ceské Republiky (Ministry of Health of the Czech Republic)</funding><pagination>22</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8901688</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>8(1)</volume><pubmed_abstract>The effect of dopaminergic medication on speech has rarely been examined in early-stage Parkinson's disease (PD) and the respective literature is inconclusive and limited by inappropriate design with lack of PD control group. The study aims to examine the short-term effect of dopaminergic medication on speech in PD using patients with good motor responsiveness to levodopa challenge compared to a control group of PD patients with poor motor responsiveness. A total of 60 early-stage PD patients were investigated before (OFF) and after (ON) acute levodopa challenge and compared to 30 age-matched healthy controls. PD patients were categorised into two clinical subgroups (PD responders vs. PD nonresponders) according to the comparison of their motor performance based on movement disorder societ</pubmed_abstract><journal>NPJ Parkinson's disease</journal><pubmed_title>Short-term effect of dopaminergic medication on speech in early-stage Parkinson's disease.</pubmed_title><pmcid>PMC8901688</pmcid><funding_grant_id>NV19-04-00120</funding_grant_id><pubmed_authors>Rusz J</pubmed_authors><pubmed_authors>Ruzicka E</pubmed_authors><pubmed_authors>Tykalova T</pubmed_authors><pubmed_authors>Novotny M</pubmed_authors><pubmed_authors>Dusek P</pubmed_authors></additional><is_claimable>false</is_claimable><name>Short-term effect of dopaminergic medication on speech in early-stage Parkinson's disease.</name><description>The effect of dopaminergic medication on speech has rarely been examined in early-stage Parkinson's disease (PD) and the respective literature is inconclusive and limited by inappropriate design with lack of PD control group. The study aims to examine the short-term effect of dopaminergic medication on speech in PD using patients with good motor responsiveness to levodopa challenge compared to a control group of PD patients with poor motor responsiveness. A total of 60 early-stage PD patients were investigated before (OFF) and after (ON) acute levodopa challenge and compared to 30 age-matched healthy controls. PD patients were categorised into two clinical subgroups (PD responders vs. PD nonresponders) according to the comparison of their motor performance based on movement disorder societ</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Mar</publication><modification>2025-04-22T22:06:25.213Z</modification><creation>2025-04-06T03:55:33.214Z</creation></dates><accession>S-EPMC8901688</accession><cross_references><pubmed>35256614</pubmed><doi>10.1038/s41531-022-00286-y</doi></cross_references></HashMap>